3D Bioprinting Market Is Expected To Grow At A Robust CAGR Of 12.9% During 2020-2030 – Future Market Insights

DUBAI, United Arab Emirates, Academic institutes and hospitals use 3D printing technology to develop various models for training purposes. The technology is increasing used in bio printing where biomaterials such as growth factors and cells are combined with bioink to create tissue-like structures that imitate natural tissues. The global 3D Bioprinting Market is estimated to surpass US$ 1.2 Bn by 2021, at the market CAGR of 12.9% during the forecast period (2020-2030), as per a new report by Future Market Insights (FMI).

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-808

3D bioprinting has immense potential to facilitate organ transplants and drug discovery. 3D printing can copy the actual macro and micro-environment of human organs and tissues which can solve the organ transplant crisis. Advancements in 3D printing technology and its promising applications in the healthcare industry are expected to increase the sale of 3D bioprinting over the forecast period.

As per the report, the technology will find increasing application in orthopedic implants manufacturing. The orthopedic implants segment is in fact forecast to account for over 30% of the market in terms of application.

Key Takeaways from 3D bioprinting Marker Study

  • Exhibiting a little below 13% Y-o-Y growth in 2021, 3D bioprinting market will exhibit solid growth
  • The U.S. will register high demand, accounting for nearly 95% of sales in North America
  • Demand in U.K. is expected to rise significantly, exhibiting above 11% Y-o-Y growth in 2021
  • France and Germany too will register high demand
  • In East Asia, China and Japan are expected to emerge as key market

For any Queries Related with the Report, Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-808

Acquisitions, Partnerships and expansion are key Strategic Focus of 3D bioprinting Market Players

Leading players in the 3D bioprinting market on strengthening their market position though the Acquisition, Partnerships and expansion. For Instance,

  • In January 2021, 3D Systems announced its regenerative and bioprinting solutions expansion by actively investing in the regenerative areas, in collaboration with United Therapeutics Corporation.
  • In December 2019, GE Healthcare Life Sciences collaborated with Advanced Solutions Life Sciences (ASLS), a Kentucky-based biotechnology firm, to build an integrated 3D bioprinter by combining their digital advanced technologies.
  • In January 2020, GE Healthcare Life Sciences introduced a new additive manufacturing (AM) facility in Umeå, Sweden that will be dedicated to integrating 3D-printed parts into the company’s production of bio manufacturing equipment. With $2 million in backing, the new center is expected to increase biopharma manufacturers’ access to state-of-the-art technologies

We Offer tailor-made Solutions to fit Your Requirements, Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-808

Who is Winning?

The global market is set to expand its scope in the forecast period, due to rising prevalence of orthopedic disease globally and adoption of 3D bioprinting at various stages of development of orthopedic implants by medical manufacturers. In addition to this, cost effectiveness and increase adaption of 3D bioprinting in dental and regenerative medicine application has augmented the sales of 3D bioprinting.

The key market players covered by FMI include 3D Systems, Inc, GE Healthcare (Concept Laser, Arcam AB), EOS GmbH Electro Optical Systems, Renishaw plc, Stratasys Ltd, Ltd, EnvisionTEC, Formlabs, Inc And Organovo Holdings Inc, and Advanced Solutions Life Sciences, consolidating their positions through mergers, acquisitions and new product launches.

Explore FMI’s Extensive ongoing Coverage on Healthcare Domain

3D Medical Implants Market - The three-dimensional (3D) medical implants are medical devices that offer aids in the medical reconstruction procedures of physical faults and abnormalities of the body.

3D Orthopedic Scanning Systems Market - 3D orthopedic scanning systems are advanced technology driven systems which are used for scanning individual’s body parts to help diagnose and treat the defect in it. The 3D orthopedic scanning systems through its scanning abilities help in designing customized items for individual and is finding increasing application in surgical practices.

3D Imaging Surgical Solution Market - 3D imaging is used to create virtual representation of the interior of the body for medical intervention and clinical analysis of complex disease in a short period during surgery. 3D imaging surgical solution is adopted by the hospitals and organizations due to better visualization and improved image.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact:

Future Market Insights,

1602-6 Jumeirah Bay X2 Tower,

Plot No: JLT-PH2-X2A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

For Sales Enquiries: sales@futuremarketinsights.com

For Media Enquiries: press@futuremarketinsights.com

Website: https://www.futuremarketinsights.com/

Report: https://www.futuremarketinsights.com/reports/3d-bio-printing-market

Back to news